Clinical Trial: The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity

U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07218445) titled 'The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity' on Oct. 03.

Brief Summary: The purpose of this study is to determine the effect of tirzepatide on vasomotor symptoms and on measures of biological aging.

Study Start Date: Sept. 16

Study Type: INTERVENTIONAL

Condition: Obesity Menopause Hot Flashes

Intervention: DRUG: Tirzepatide

Tirzepatide will be administered with a starting dose of 2.5 mg weekly, subcutaneously injected. The dose will increase by 2.5 mg every 4 weeks until reaching 15 mg.

Participants will be asked to follow lifestyle interventions:

* L...